Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

An Update on Self-Amplifying mRNA Vaccine Development

Version 1 : Received: 16 December 2020 / Approved: 18 December 2020 / Online: 18 December 2020 (11:12:44 CET)

A peer-reviewed article of this Preprint also exists.

Blakney, A.K.; Ip, S.; Geall, A.J. An Update on Self-Amplifying mRNA Vaccine Development. Vaccines 2021, 9, 97. Blakney, A.K.; Ip, S.; Geall, A.J. An Update on Self-Amplifying mRNA Vaccine Development. Vaccines 2021, 9, 97.

Journal reference: Vaccines 2021, 9, 97
DOI: 10.3390/vaccines9020097

Abstract

This review will explore the four major pillars required for design and development of an saRNA vaccine: antigen design, vector design, non-viral delivery systems, and manufacturing (both saRNA and lipid nanoparticles (LNP)). In will report on the major innovations, preclinical and clinical data reported in the last five years and will discuss future prospects.

Subject Areas

RNA; self-amplifying RNA; replicon; vaccine; drug delivery

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.